Is Veradermics profitable?

Veradermics is not currently profitable: it reported a net loss of $52.9M over the trailing twelve months.

What is Veradermics 's earnings per share?

Veradermics 's diluted EPS over the trailing twelve months is $-39.63.

Where does Veradermics 's income statement data come from?

Every line is extracted from Veradermics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Veradermics MANE Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$20.93M+82.8%	——	——	——	$11.45M+96.7%
General and administrative	$8.94M+509%	——	——	——	$1.47M+68.0%
Other operating expenses	$29.86M+131%	——	——	——	$12.92M+92.9%
Total operating expenses	$29.86M+131%	——	——	——	$12.92M+92.9%
Operating income	-$29.86M-131%	——	——	——	-$12.92M-92.9%
Interest expense	——	$0-100%	$0-100%	$0-100%	$0-100%
Interest income	$2.48M+415%	——	——	——	$482K+301%
Other income (expense), net	$2.63M+411%	——	——	——	$515K+610%
Income before income taxes	-$27.23M-120%	——	——	——	-$12.4M-87.3%
Income tax expense	$0—	——	——	——	$0—
Net income	-$27.23M-120%	——	——	——	-$12.4M-87.3%
Diluted earnings per share	-$1.32+93.3%	——	——	——	-$19.79-114%
Basic earnings per share	-$1.32+93.3%	——	——	——	-$19.79-114%
Weighted-average shares, diluted	22.7M+2,981%	745K+1.1%	——	——	736.9K—
Weighted-average shares, basic	22.7M+2,981%	745K+1.1%	——	——	736.9K—
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$27.82M-124%	——	——	——	-$12.4M-87.3%
Unrealized gains (losses) on available-for-sale securities	-$584K—	——	——	——	$0—
Other Nonoperating Income	$149K+352%	——	——	——	$33K-66.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Veradermics profitable?: Veradermics is not currently profitable: it reported a net loss of $52.9M over the trailing twelve months.
What is Veradermics 's earnings per share?: Veradermics 's diluted EPS over the trailing twelve months is $-39.63.
Where does Veradermics 's income statement data come from?: Every line is extracted from Veradermics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.